Memorial Sloan Kettering Suffolk-Commack (Limited protocol activity) is a clinical research site located in Commack, New York, United States 11725.
Crixeo Health Trust Score: 72/100 (FAIR). This profile has not yet been claimed by the site owner.
Memorial Sloan Kettering Suffolk-Commack (Limited protocol activity) has participated in 11 clinical trials with 11 currently active.
Therapeutic areas: T-cell Lymphoma, Esophageal Cancer, Gastric Adenocarcinoma.
Sponsors: Memorial Sloan Kettering Cancer Center, Icahn School of Medicine at Mount Sinai.
Trust Score: 72/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Memorial Sloan Kettering Suffolk-Commack (Limited protocol activity) has a Crixeo Trust Score of 72/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Memorial Sloan Kettering Suffolk-Commack (Limited protocol activity) has 11 clinical trials on record, with 11 currently active. Their work covers T-cell Lymphoma, Esophageal Cancer, Gastric Adenocarcinoma.
Yes — Memorial Sloan Kettering Suffolk-Commack (Limited protocol activity) holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.